State-of-the-Art Digital Pathology | CellCarta
The beauty of better results with digital assays and AI-driven image analysis!
Our 21 CFR-part 11 compliant digital image analysis workflow ensures high-quality clinical insights. We provide detailed H&E and IHC/IF/ISH image analysis using advanced software with AI capabilities to support your clinical studies.
Discover the art of digital analysis!
CellCarta’s digital pathology expertise combines a meticulous digital assay workflow with comprehensive image analysis.
- Complete H&E evaluations
- Detailed image annotations
- Strict quality checks by our analysts and pathologists
- Easy-to-navigate data reports.
Download the resource
As a global CRO, we prioritize your study goals and clinical trial needs above all else. We aim to provide you with easy, accessible, and comprehensive technologies spanning a multitude of therapeutic areas.
Discover our range of services in immunology, proteomics, genomics, as well as related ML/AI and sample logistics services.
State-of-the-Art Digital Pathology | CellCarta
The beauty of better results with digital assays and AI-driven image analysis!
Our 21 CFR-part 11 compliant digital image analysis workflow ensures high-quality clinical insights. We provide detailed H&E and IHC/IF/ISH image analysis using advanced software with AI capabilities to support your clinical studies.
Discover the art of digital analysis!
CellCarta’s digital pathology expertise combines a meticulous digital assay workflow with comprehensive image analysis.
- Complete H&E evaluations
- Detailed image annotations
- Strict quality checks by our analysts and pathologists
- Easy-to-navigate data reports.
Download the resource
As a global CRO, we prioritize your study goals and clinical trial needs above all else. We aim to provide you with easy, accessible, and comprehensive technologies spanning a multitude of therapeutic areas.
Discover our range of services in immunology, proteomics, genomics, as well as related ML/AI and sample logistics services.
Case Study: Streamline Your Adoptive Cell Therapy Program With Digital PCR (dPCR)
October 19, 2022
CellCarta is your one partner for your adoptive cell therapy program by offering a complete suite of services with complementary platforms:
- Patient selection with key biomarkers
- Monitoring engineered cells with digital PCR
- Monitoring therapeutic responses with multiplex flow cytometry
- Evaluating your combination therapy
- Simplifying toxicity assessment
Download our case study on digital PCR.
Our team has unique expertise in digital PCR to support you in ensuring your adoptive cell therapy meets safety regulations relating to vector copy number (VCN).
Download the case study for an overview on dPCR:
- How it works
- How dPCR compares to quantitative PCR
- Key clinical applications including VCN measurement and RCR/RCL detection under regulatory standards
- Data on measuring VCN using dPCR in a phase 1 clinical trial
Partners in Laboratory Testing
As a global Contract Research Organization Laboratory (CRO) to the biopharmaceutical industry, CellCarta provides access to a broad offering of biomarker platforms and services. We partner with you to address the most complex laboratory testing needs, delivering customized biomarker testing solutions to further the limitless potential of precision medicine.
Case Study: Streamline Your Adoptive Cell Therapy Program With Digital PCR (dPCR)
October 19, 2022
CellCarta is your one partner for your adoptive cell therapy program by offering a complete suite of services with complementary platforms:
- Patient selection with key biomarkers
- Monitoring engineered cells with digital PCR
- Monitoring therapeutic responses with multiplex flow cytometry
- Evaluating your combination therapy
- Simplifying toxicity assessment
Download our case study on digital PCR.
Our team has unique expertise in digital PCR to support you in ensuring your adoptive cell therapy meets safety regulations relating to vector copy number (VCN).
Download the case study for an overview on dPCR:
- How it works
- How dPCR compares to quantitative PCR
- Key clinical applications including VCN measurement and RCR/RCL detection under regulatory standards
- Data on measuring VCN using dPCR in a phase 1 clinical trial
Partners in Laboratory Testing
As a global Contract Research Organization Laboratory (CRO) to the biopharmaceutical industry, CellCarta provides access to a broad offering of biomarker platforms and services. We partner with you to address the most complex laboratory testing needs, delivering customized biomarker testing solutions to further the limitless potential of precision medicine.
